2-amino>ethanol | 17225-70-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-amino>ethanol
• 英文别名: N-(2-hydroxyethyl)-N,N′-dimethylethylenediamine；N,N’-dimethyl-N-ethanolethylenediamine；N,N'-Dimethyl-N-(2-hydroxyethyl)-ethylendiamin；N,N'-Dimethyl-N'-(2-hydroxy-aethyl)-aethylendiamin；2-(N-methyl-N-{2-(methylamino)ethyl}amino)ethanol；N,N'-dimethyl-N-(2hydroxyethyl)ethylenediamine；2-{methyl[2-(methylamino)ethyl]amino}ethanol；2-{Methyl[2-(methylamino)ethyl]amino}ethan-1-ol；2-[methyl-[2-(methylamino)ethyl]amino]ethanol
• CAS: 17225-70-6
• 化学式: C₆H₁₆N₂O
• 分子量: 132.206
• InChiKey: AFYRRIVBYFQVJL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-甲基-2-恶唑烷酮 、 DL-氨基丙醇 生成 2-amino>ethanol
  参考文献：
  名称：

  Aminoethylation process for production of substituted ethylene diamines

  摘要：

  揭示了一种生产取代乙二胺的过程，该过程包括将氧杂环丙酮酮与二级胺或烷基醇胺反应。该过程在某一方面包括原位反应氧杂环丙酮的前体。

  公开号：

  US05491263A1

文献信息

• [EN] NOVEL IMIDAZOPYRAZINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'IMIDAZOPYRAZINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2020126954A1

  公开（公告）日：2020-06-25

  The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

  该发明提供了具有通式（I）的新型咪唑吡嗪衍生物，其中A和R1至R11如本文所述（I），以及其药学上可接受的盐。还提供了包括这些化合物的药物组合物、制造这些化合物的方法以及将这些化合物用作药物的方法，特别是将这些化合物用作抗生素治疗或预防细菌感染和相关疾病的方法。
• NOVEL COMPOUNDS 515
  申请人：Ducray Richard

  公开号：US20100105655A1

  公开（公告）日：2010-04-29

  There is provided novel pyrimidine derivatives of formula (I) or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  提供了化学式（I）的新型嘧啶衍生物或其药用盐，以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的应用。
• Sulfonamide compound
  申请人：Matsubara Koki

  公开号：US20090048223A1

  公开（公告）日：2009-02-19

  A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G 1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G 2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; G 3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkoxycarbonyl group, an acyl group, an acyloxy group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; Y represents a single bond, or —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, or an alkyl group, or alkylene groups which combine together to form a saturated hydrocarbon ring group); G 4 represents hydroxyl group (Y is a single group), or —N(R 1 )(R 2 ) (R 1 and R 2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, a saturated heterocyclic group, an alkylsulfonyl group, an acyl group, or an amidino group); G 5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.

  由以下化学式表示的化合物：[A代表含氮饱和环；m表示0到2的整数；n表示1到4的整数；G1代表氢原子、氯原子、羟基、烷氧基或氨基；G2代表卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；G3代表氢原子、卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；Y代表单键，或-C(R3)(R4)-（R3和R4代表氢原子、烷基或烷烯基，它们结合在一起形成饱和碳氢环基）；G4代表羟基（Y是单个基），或-N(R1)(R2)（R1和R2代表氢原子、烷基、芳基、烯基、炔基、饱和杂环基、烷基磺酰基、酰基或胺基）；G5是A的环构成碳原子上的取代基，代表氢原子、氟原子或烷基]或其盐、或作为前药的衍生物，其强力抑制Rho激酶。
• Chemical Stability of Secondary-alkanolamine-based CO₂ Solvents under Stripping Conditions
  作者：Shin Yamamoto、Takayuki Higashii

  DOI：10.1246/cl.130688

  日期：2013.12.5

  Chemical stabilities of secondary alkanolamine substrates in CO2 solvents under stripping conditions and generation pathways of thermal degradation products have been studied. The two products generated in each amine solution have been proven to be oxazolidone and dimer of each amine. The thermal degradation of secondary alkanolamine proceeds in two steps as consecutive reactions. The carbamate compound, which is CO2-absorbing amine, cyclodehydrates to generate oxazolidone, and the oxazolidone further reacts with another amine to generate dimer through decarbonation condensation.

  研究了仲烷醇胺底物在二氧化碳溶剂中剥离条件下的化学稳定性以及热降解产物的生成途径。经证实，在每种胺溶液中生成的两种产物分别是噁唑烷酮和每种胺的二聚物。仲烷醇胺的热降解过程分为两个连续反应步骤。作为二氧化碳吸收胺的氨基甲酸酯化合物发生环脱水反应生成恶唑烷酮，恶唑烷酮再与另一种胺发生脱碳缩合反应生成二聚体。
• [EN] C-4" POSITION SUBSTITUTED MACROLIDE DERIVATIVE<br/>[FR] DÉRIVÉ DE MACROLIDE SUBSTITUÉ EN POSITION C-4"
  申请人：TAISHO PHARMA CO LTD

  公开号：WO2012115256A1

  公开（公告）日：2012-08-30

  A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).

  一种由化学式（I）表示的大环内酯化合物，对红霉素耐药细菌有效（例如，耐药的肺炎球菌、链球菌和支原体）。